Cargando…
Nicotinamide Prevents Apolipoprotein B-Containing Lipoprotein Oxidation, Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice
The potential of nicotinamide (NAM) to prevent atherosclerosis has not yet been examined. This study investigated the effect of NAM supplementation on the development of atherosclerosis in a mouse model of the disease. The development of aortic atherosclerosis was significantly reduced (NAM low dose...
Autores principales: | Méndez-Lara, Karen Alejandra, Letelier, Nicole, Farre, Nuria, Diarte-Añazco, Elena M. G., Nieto-Nicolau, Núria, Rodríguez-Millán, Elisabeth, Santos, David, Pallarès, Victor, Escolà-Gil, Joan Carles, Vázquez del Olmo, Tania, Lerma, Enrique, Camacho, Mercedes, Casaroli-Marano, Ricardo P, Valledor, Annabel F., Blanco-Vaca, Francisco, Julve, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700561/ https://www.ncbi.nlm.nih.gov/pubmed/33233455 http://dx.doi.org/10.3390/antiox9111162 |
Ejemplares similares
-
Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
por: Rivas-Urbina, Andrea, et al.
Publicado: (2020) -
Novel Insights into the Role of HDL-Associated Sphingosine-1-Phosphate in Cardiometabolic Diseases
por: Diarte-Añazco, Elena M. G., et al.
Publicado: (2019) -
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
por: Rotllan, Noemi, et al.
Publicado: (2021) -
Nicotinamide Prevents Diabetic Brain Inflammation via NAD+-Dependent Deacetylation Mechanisms
por: Torres-Méndez, Jeimy Katherine, et al.
Publicado: (2023) -
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future
por: Julve, Josep, et al.
Publicado: (2021)